These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38628627)

  • 21. Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis.
    Xie J; Zhang T; Li P; Wang D; Liu T; Xu S
    Drug Des Devel Ther; 2022; 16():3071-3085. PubMed ID: 36118165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway.
    Zhao Y; Liu X; Ding C; Gu Y; Liu W
    Front Pharmacol; 2021; 12():783886. PubMed ID: 34867416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells.
    Liu B; Tan X; Liang J; Wu S; Liu J; Zhang Q; Zhu R
    Sci Rep; 2014 Nov; 4():7041. PubMed ID: 25391369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway.
    Shi L; Zhang T; Liang X; Hu Q; Huang J; Zhou Y; Chen M; Zhang Q; Zhu J; Mi M
    Mol Cell Endocrinol; 2015 Jul; 409():92-102. PubMed ID: 25797177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of Dihydromyricetin on Inflammatory Diseases.
    Sun Y; Liu S; Yang S; Chen C; Yang Y; Lin M; Liu C; Wang W; Zhou X; Ai Q; Wang W; Chen N
    Front Pharmacol; 2021; 12():794563. PubMed ID: 35115939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydromyricetin inhibits African swine fever virus replication by downregulating toll-like receptor 4-dependent pyroptosis in vitro.
    Chen Y; Song Z; Chang H; Guo Y; Wei Z; Sun Y; Gong L; Zheng Z; Zhang G
    Vet Res; 2023 Jul; 54(1):58. PubMed ID: 37438783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
    Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
    Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
    [No Abstract]   [Full Text] [Related]  

  • 28. Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
    Liu B; Zhou W; Chen X; Xu F; Chen Y; Liu J; Zhang Q; Bao S; Chen N; Li M; Zhu R
    Mol Med Rep; 2015 Mar; 11(3):1609-14. PubMed ID: 25376731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells.
    Wang F; Chen X; Yuan D; Yi Y; Luo Y
    PLoS One; 2019; 14(11):e0225450. PubMed ID: 31770410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
    Jiang L; Ye WC; Li Z; Yang Y; Dai W; Li M
    BMC Complement Med Ther; 2021 Jul; 21(1):194. PubMed ID: 34229692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy.
    Chen Y; Lv L; Pi H; Qin W; Chen J; Guo D; Lin J; Chi X; Jiang Z; Yang H; Jiang Y
    Oncotarget; 2016 Nov; 7(47):76508-76522. PubMed ID: 27793014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.
    Hu Q; Zhang T; Yi L; Zhou X; Mi M
    Biofactors; 2018 Mar; 44(2):123-136. PubMed ID: 29193391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydromyricetin Alleviates High Glucose-Induced Oxidative Stress and Apoptosis in Human Retinal Pigment Epithelial Cells by Downregulating miR-34a Expression.
    Li W; Xiao H
    Diabetes Metab Syndr Obes; 2021; 14():387-397. PubMed ID: 33536772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.
    Ren ZX; Zhao YF; Cao T; Zhen XC
    Acta Pharmacol Sin; 2016 Sep; 37(10):1315-1324. PubMed ID: 27374489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells.
    Huang X; Lian T; Guan X; Liu B; Hao S; Zhang J; Bao S; Tan X; Zhu R
    Protein Pept Lett; 2017; 24(5):419-424. PubMed ID: 28240161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis.
    Xu Z; Zhang M; Wang W; Zhou S; Yu M; Qiu X; Jiang S; Wang X; Tang C; Li S; Wang CH; Zhu R; Peng WX; Zhao L; Fu X; Patzak A; Persson PB; Zhao L; Mao J; Shu Q; Lai EY; Zhang G
    Toxicol Appl Pharmacol; 2023 Aug; 473():116595. PubMed ID: 37328118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway.
    Kou X; Liu X; Chen X; Li J; Yang X; Fan J; Yang Y; Chen N
    Oncotarget; 2016 Nov; 7(46):74484-74495. PubMed ID: 27780933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines.
    Hsin MC; Hsiao YH; Chen PN; Lin CW; Wang PH; Yang SF; Lee CY
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway.
    Shi L; Zhang T; Zhou Y; Zeng X; Ran L; Zhang Q; Zhu J; Mi M
    Endocrine; 2015 Nov; 50(2):378-89. PubMed ID: 25896550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating miR-155-5p/PTEN signaling in diabetic nephropathy.
    Guo L; Tan K; Luo Q; Bai X
    Bosn J Basic Med Sci; 2020 Aug; 20(3):372-380. PubMed ID: 31668144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.